Column Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $6.58K | Hold |
145
| – | – | ﹤0.01% | 571 |
|
|
2023
Q2 | $8.14K | Hold |
145
| – | – | ﹤0.01% | 562 |
|
|
2023
Q1 | $6.56K | Hold |
145
| – | – | ﹤0.01% | 610 |
|
|
2022
Q4 | $5.89K | Hold |
145
| – | – | ﹤0.01% | 597 |
|
|
2022
Q3 | $9K | Hold |
145
| – | – | ﹤0.01% | 479 |
|
|
2022
Q2 | $9K | Hold |
145
| – | – | ﹤0.01% | 489 |
|
|
2022
Q1 | $9K | Hold |
145
| – | – | ﹤0.01% | 512 |
|
|
2021
Q4 | $11K | Buy |
145
+58
| +67% | +$4.4K | ﹤0.01% | 496 |
|
|
2021
Q3 | $10K | Hold |
87
| – | – | ﹤0.01% | 465 |
|
|
2021
Q2 | $14K | Buy |
87
+45
| +107% | +$7.24K | ﹤0.01% | 425 |
|
|
2021
Q1 | $5K | Buy |
+42
| New | +$5K | ﹤0.01% | 531 |
|
|
2020
Q1 | – | Sell |
-61
| Closed | -$3K | – | 735 |
|
|
2019
Q4 | $3K | Buy |
+61
| New | +$3K | ﹤0.01% | 568 |
|